Cryoprecipitate contains Fibrinogen, Fibronectin, VWF, XIII, VIII
Effective in the management of bleeding :
- Hypofibrinogemia
- liver disease
- DIC
- Uremia (if DDAVP is ineffective)
- Factor XIII (if XIII is unavailable)
- Hemophilia A (if VIII is unavailable)
- VWD (if vWF

Oncologist leaving the clinic after seeing 27 patients! #MedTwitter #oncology #hematology #mmsm #myeloma

Can the President Biden give something for the ICE-T symposium! We are trying our best to get cell therapy available to all #myeloma patients! We Just want 2-3 million dollars! #USMIRC USMIRC News #MedEd #MedTwitter #mmsm

What is the purpose of insurance companies in the current health system?

1) They believe that all insurers should be healthy, 2) they deny any medical service if possible, and 3) They do not believe in medical emergencies!

The only benefit is their CEO's wallet gets Thicker

THE OncoAlert 🚨5K REGISTRATION at #ASCO24

Saturday, June 1st at 7am (Chicago)
Start Hyatt Regency at McCormick Place , Chicago

Countries of Colleagues participating:
🇺🇸🇩🇪🇹🇷🇫🇷🇸🇪🇲🇽🇮🇹🇮🇳🇧🇪🇭🇺🇲🇦🇦🇹🇱🇧🇮🇪🇬🇭
oncoalert.m-pages.com/T8RKPR/the-onc…

A warm welcome to our Congress Hosts/ friends/

Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Who Received at Least 2 BCMA-Directed Therapies
#mmsm #myeloma #MedEd #Medtwitter #USMIRC USMIRC News
sciencedirect.com/science/articl…

Fit myeloma pt on Lenalidomide maintenance with mildly elevated sFLC <10 mg/dL, no end organ damage! We must be careful before offering Cilta-Cel! #myeloma is not a number! Just saying 🤷‍♂️
#mmsm #medtwitter #MedEd #USMIRC USMIRC News

Picture of the week UEFA Champions League! #UCL

One of my patients appreciates our #USMIRC group projects, especially the GLAMM study ASH! It's incredibly uplifting to know that our efforts are valued 🙏

ash.confex.com/ash/2023/webpr…

#mmsm #Myeloma #MedEd #USMIRC USMIRC News

Idecabtagene Vicleucel in Early Relapsed/Refractory Myeloma: Is There an Efficacy Benefit?
dailynews.ascopubs.org/do/idecabtagen…
ASCO #ASCOdailyNews #medtwitter USMIRC News #USMIRC Shebli Atrash KU Cancer Center #mmsm #myeloma

Oh Congratulations Real Madrid C.F. 🎉🎊🎈

Idecabtagene Vicleucel in Early Relapsed/Refractory Myeloma: Is There an Efficacy Benefit? | ASCO Daily News
url.us.m.mimecastprotect.com/s/UwVACM825xuq…
#ASCODailyNews ASCO USMIRC News #mmsm #myeloma #USMIRC Shebli Atrash Al-Ola A Abdallah MD (USMIRC)